The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
High Speed Video To Assess Eye Movements In Vestibular Dysfunction - A Validation Study
Funder
National Health and Medical Research Council
Funding Amount
$133,351.00
Summary
Dizziness affects a third of the population during their lives. Abnormal eye movements are often the best guide as to what has gone wrong in the dizzy person. The problem is that these eye movements can be difficult to see, and hence measure, as a way of diagnosing and then treating the dizziness. Video-oculography holds great promise for helping doctors identify the cause, and in many cases offer simple curative treatment, for dizziness.
Environmental Risk Factors For Primary Progressive Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$86,118.00
Summary
Primary Progressive Multiple Sclerosis (PPMS) is a form of MS affecting 10% of people with the disease. PPMS has been less researched than the more common form of MS, Relapsing Remitting MS (RRMS), and unlike RRMS, there are currently no effective treatments. This project will examine whether the established risk factors for RRMS also hold for PPMS, whether the magnitude of risk associated with these factors is the same for PPMS, and whether novel risk factors for PPMS can be identified.
Does Rehabilitation Increase The Functional Independence Of People With Friedreich Ataxia?
Funder
National Health and Medical Research Council
Funding Amount
$81,811.00
Summary
Friedreich Ataxia (FRDA) is a disease which reduces the ability to walk. People decline rapidly and are usually dependent on a wheel-chair by 20-30 years of age. This research will examine the impact of changes in leg function, including strength and balance, on the capacity to walk. This research will determine if rehabilitation can improve walking ability and reduce the decline in FRDA. The results of this research will ensure people with FRDA are provided with the most appropriate care.
Social Functioning And Autism Spectrum Disorder In Children With Neurofibromatosis Type 1: A Multimodal Study.
Funder
National Health and Medical Research Council
Funding Amount
$107,204.00
Summary
Social difficulties and symptoms of autism spectrum disorder (ASD) are frequently found in children with neurofibromatosis type 1 (NF1), a common genetic condition. The current study will examine (1) prevalence and characteristics of ASD and social impairment in children with NF1, (2) cognitive factors contributing to ASD symptoms and (3) associated compromise to brain structure. Findings are expected to guide development of treatments to improve social functioning in children with NF1.
Clinical Genetics Studies Of Speech And Language Disorders In Large Families.
Funder
National Health and Medical Research Council
Funding Amount
$160,368.00
Summary
Childhood speech and language disorders are common and may have negative long term outcomes. We have a limited understanding of what causes these disorders, which impacts our ability to manage and treat those affected. This project will utilise large families to investigate causes and clinical features of speech and language disorders. This is an exciting and relatively under-research area, and has the potential to lead to improved outcomes for children affected with speech and language disorder ....Childhood speech and language disorders are common and may have negative long term outcomes. We have a limited understanding of what causes these disorders, which impacts our ability to manage and treat those affected. This project will utilise large families to investigate causes and clinical features of speech and language disorders. This is an exciting and relatively under-research area, and has the potential to lead to improved outcomes for children affected with speech and language disorder.Read moreRead less
The Incidence And Genetics Of The Infantile Epileptic Encephalopathies
Funder
National Health and Medical Research Council
Funding Amount
$175,224.00
Summary
Severe epilepsies with frequent seizures and cognitive impairments in the first 18 months of life are known as ‘infantile epileptic encephalopathies’ (IEE). The cause of IEE is unknown in many patients, although presumed genetic. This study of patients with IEE in Victoria aims to describe the incidence of IEE, and understand the genetic causes of IEE. Understanding the causes of IEE will be the first step towards development of urgently-needed novel therapies for these devastating conditions.
Advances In The Understanding Of Autoimmune Encephalitides And Associated Movement Disorders In Children
Funder
National Health and Medical Research Council
Funding Amount
$68,832.00
Summary
Encephalitis in childhood can be devastating with long lasting effects and mortality. This research focuses on children who suffer from encephalitis due to an autoimmune process. In such cases many children present with involuntary abnormal body movements. This project will explore whether differences in the nature of these movements or in electroencephalography or brain imaging with MRI, can help early differentiation of different types of autoimmune encephalitis.
Lewy body dementia is a common yet under-recognised form of dementia in older people. There is a great need for biomarkers to reduce misdiagnosis and improve outcomes for patients and families. Recently there have been exciting advances in research regarding blood tests that might improve diagnosis and understanding of dementia. We will study these blood markers of neurodegeneration and inflammation in people with Lewy body dementia, which may improve diagnosis and help discover new treatments.
Neurobiology Of Relaxin-3/RXFP3 Systems: Anatomical And Functional Studies In Transgenic Mice
Funder
National Health and Medical Research Council
Funding Amount
$94,242.00
Summary
Mental illness is an economic and health burden worldwide, with huge costs in medical spending, lost productivity, poor quality of life for sufferers and mortality. Relaxin-3 is a peptide that acts widely within neural circuits to modulate brain activity that is altered in conditions such as anxiety and mood/sleep disorders. Our research assessing the effect of genetic removal of relaxin-3 signaling on behaviour will add to our knowledge of brain function and improve mental health outcomes.
Clinical Phenotypes And Novel Neurophysiological And Immunological Biomarkers In Inflammatory Neuropathy And Neurodegeneration
Funder
National Health and Medical Research Council
Funding Amount
$83,970.00
Summary
The aim of this project is to define subgroups of inflammatory neuropathies by correlating clinical phenotypes with immunological & neurophysiological profiles. The identification of specific autoantibody markers in patients with inflammatory neuropathies will aid in diagnosis &differentiation from motor neurodegenerative disorders. Identification of prognostic novel biomarkers that predict response to immunotherapy will be invaluable in the clinical setting & allow for better treatment planning